Matches in SemOpenAlex for { <https://semopenalex.org/work/W1567116736> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W1567116736 endingPage "46" @default.
- W1567116736 startingPage "41" @default.
- W1567116736 abstract "Rave parties, all-night dance parties based on techno music, represent an increasing phenomenon in France. Rave drugs refers to a wide variety of drugs used by the young participants owing to their hallucinogenic or stimulant effects. Uncertainties about the sources of these substances, the possible contaminants and the multiplicity of the associations make it difficult to evaluate the toxic consequences that might be expected in this particular context. This report presents toxicological cases documented by analytical findings in which two pharmacological agents abused in rave parties in South-West of France were found. The day following a party, a 17 year-old girl showed a confused state with drowsiness and hallucinations. She confessed having consumed a white powder sold as ecstasy, that sample analysis identified as pure ketamine. Ketamine is an anaesthetic agent primarily used in veterinary medicine and paediatrics. This drug seems to be abused, mainly by the intranasal route, owing to its hallucinogen effects. Its used in rave-party appears to be marked by unsuspected consumption. All long another party, a large quantity of orange tablets were sold and abused by several participants. Analysis performed on some fragments of these tablets revealed the presence of prolintane and ascorbic acid. Prolintane, an amphetamine-related substance, is a central nervous system stimulant. This compound is freely available in Spain in combination with several vitamins, under the form of tablets with orange coating named Katovit and sold at low price: 1.93 €/20 tablets (200 mg of prolintane)." @default.
- W1567116736 created "2016-06-24" @default.
- W1567116736 creator A5003712720 @default.
- W1567116736 creator A5011321855 @default.
- W1567116736 creator A5013698425 @default.
- W1567116736 creator A5016106089 @default.
- W1567116736 creator A5017371111 @default.
- W1567116736 date "2002-01-01" @default.
- W1567116736 modified "2023-10-16" @default.
- W1567116736 title "NOUVELLES DROGUES DE « RAVE-PARTIES » : KETAMINE ET PROLINTANE" @default.
- W1567116736 cites W1542672304 @default.
- W1567116736 cites W1967089450 @default.
- W1567116736 cites W1975454277 @default.
- W1567116736 cites W2054149100 @default.
- W1567116736 cites W2059253471 @default.
- W1567116736 cites W2088742892 @default.
- W1567116736 cites W2156177514 @default.
- W1567116736 cites W2463154691 @default.
- W1567116736 doi "https://doi.org/10.1179/acb.2002.076" @default.
- W1567116736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24862524" @default.
- W1567116736 hasPublicationYear "2002" @default.
- W1567116736 type Work @default.
- W1567116736 sameAs 1567116736 @default.
- W1567116736 citedByCount "7" @default.
- W1567116736 countsByYear W15671167362012 @default.
- W1567116736 countsByYear W15671167362014 @default.
- W1567116736 countsByYear W15671167362015 @default.
- W1567116736 countsByYear W15671167362022 @default.
- W1567116736 countsByYear W15671167362023 @default.
- W1567116736 crossrefType "journal-article" @default.
- W1567116736 hasAuthorship W1567116736A5003712720 @default.
- W1567116736 hasAuthorship W1567116736A5011321855 @default.
- W1567116736 hasAuthorship W1567116736A5013698425 @default.
- W1567116736 hasAuthorship W1567116736A5016106089 @default.
- W1567116736 hasAuthorship W1567116736A5017371111 @default.
- W1567116736 hasConcept C118552586 @default.
- W1567116736 hasConcept C124315065 @default.
- W1567116736 hasConcept C126322002 @default.
- W1567116736 hasConcept C151730666 @default.
- W1567116736 hasConcept C2777193897 @default.
- W1567116736 hasConcept C2779343474 @default.
- W1567116736 hasConcept C2779488553 @default.
- W1567116736 hasConcept C2780035454 @default.
- W1567116736 hasConcept C2780557958 @default.
- W1567116736 hasConcept C2780795376 @default.
- W1567116736 hasConcept C2910738821 @default.
- W1567116736 hasConcept C513476851 @default.
- W1567116736 hasConcept C71924100 @default.
- W1567116736 hasConcept C86803240 @default.
- W1567116736 hasConceptScore W1567116736C118552586 @default.
- W1567116736 hasConceptScore W1567116736C124315065 @default.
- W1567116736 hasConceptScore W1567116736C126322002 @default.
- W1567116736 hasConceptScore W1567116736C151730666 @default.
- W1567116736 hasConceptScore W1567116736C2777193897 @default.
- W1567116736 hasConceptScore W1567116736C2779343474 @default.
- W1567116736 hasConceptScore W1567116736C2779488553 @default.
- W1567116736 hasConceptScore W1567116736C2780035454 @default.
- W1567116736 hasConceptScore W1567116736C2780557958 @default.
- W1567116736 hasConceptScore W1567116736C2780795376 @default.
- W1567116736 hasConceptScore W1567116736C2910738821 @default.
- W1567116736 hasConceptScore W1567116736C513476851 @default.
- W1567116736 hasConceptScore W1567116736C71924100 @default.
- W1567116736 hasConceptScore W1567116736C86803240 @default.
- W1567116736 hasIssue "sup1" @default.
- W1567116736 hasLocation W15671167361 @default.
- W1567116736 hasLocation W15671167362 @default.
- W1567116736 hasOpenAccess W1567116736 @default.
- W1567116736 hasPrimaryLocation W15671167361 @default.
- W1567116736 hasRelatedWork W2047074681 @default.
- W1567116736 hasRelatedWork W2056261950 @default.
- W1567116736 hasRelatedWork W2111058155 @default.
- W1567116736 hasRelatedWork W2145879190 @default.
- W1567116736 hasRelatedWork W2417924258 @default.
- W1567116736 hasRelatedWork W2586592319 @default.
- W1567116736 hasRelatedWork W4211129494 @default.
- W1567116736 hasRelatedWork W4242305733 @default.
- W1567116736 hasRelatedWork W52121689 @default.
- W1567116736 hasRelatedWork W74911118 @default.
- W1567116736 hasVolume "57" @default.
- W1567116736 isParatext "false" @default.
- W1567116736 isRetracted "false" @default.
- W1567116736 magId "1567116736" @default.
- W1567116736 workType "article" @default.